This functional complexity is supported by clinical findings showing altered expression of HVEM, BTLA, and LIGHT in patients with IBD and related gastrointestinal disorders at different disease stages (36, 53, 54). The gene discussed is TNFRSF14; the disease is inflammatory bowel disease.